title: Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene.
abstract: Neonatal hyperinsulinism (HI) is a genetic disorder of pancreatic beta-cells characterized by failure to suppress insulin secretion in the presence of hypoglycemia, resulting in brain damage or death if not adequately treated. Germline mutations in four genes have been associated with HI. Some patients have focal regions of beta-cell proliferation (focal HI). Seventy HI probands in whom at least one SUR-1 mutation was identified were studied. Clinical data from patients with two SUR-1 mutant alleles were compared with those from patients with single paternally inherited mutations. Thirty-seven probands were homozygous or compound heterozygous for SUR-1 mutations. In 33 probands, only a single mutation was identified, and in 31, the parental origin of the proband could be determined; in 29, the mutation was on the paternal allele (P < 0.0002). For three of these, pancreatic tissue was available and showed focal beta-cell hyperplasia. DNA extracted from the focal lesion and adjacent normal pancreas revealed loss of the maternal chromosome 11p15, resulting in reduction to homozygosity for the SUR-1 mutation within the focal lesion only. Using the Tdt-mediated dUTP nick end labeling (TUNEL) reaction, apoptotic beta-cells were identified exclusively within the focal region. At diagnosis, disease severity was similar in patients with paternally inherited mutations and those with two mutations. For patients who did not undergo surgery, those with only paternal mutations entered clinical remission within 16 +/- 6.2 months, compared with 48 +/- 23 months for those with two SUR-1 mutations (P = 0.001). In conclusion, we identified a novel mechanism to explain the pathophysiology of focal HI and provide evidence to suggest that this entity may be self-limiting, since affected beta-cells undergo apoptosis.
authors.affiliation: Department of Endocrinology and Metabolism, Hebrew University, Hadassah Medical School, Jerusalem, Israel. beng@cc.huji.ac.il
authors.forename: B
authors.initials: B
authors.lastname: Glaser
authors.forename: F
authors.initials: F
authors.lastname: Ryan
authors.forename: M
authors.initials: M
authors.lastname: Donath
authors.forename: H
authors.initials: H
authors.lastname: Landau
authors.forename: C A
authors.initials: CA
authors.lastname: Stanley
authors.forename: L
authors.initials: L
authors.lastname: Baker
authors.forename: D E
authors.initials: DE
authors.lastname: Barton
authors.forename: P S
authors.initials: PS
authors.lastname: Thornton
mesh_terms: D018528:ATP-Binding Cassette Transporters; D000483:Alleles; D017209:Apoptosis / Q000502:physiology; D002880:Chromosomes, Human, Pair 11 / Q000235:genetics; D005220:Fathers; D017353:Gene Deletion; D005808:Genes, Recessive / Q000235:genetics*; D006720:Homozygote; D006801:Humans; D006946:Hyperinsulinism / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology / Q000601:surgery; D006965:Hyperplasia; D007223:Infant; D007231:Infant, Newborn; D007515:Islets of Langerhans / Q000473:pathology; D008297:Male; D009035:Mothers; D009154:Mutation / Q000502:physiology*; D015221:Potassium Channels / Q000235:genetics*; D024661:Potassium Channels, Inwardly Rectifying; D011955:Receptors, Drug / Q000235:genetics*; D064233:Sulfonylurea Receptors
chemical_list: C577507:ABCC8 protein, human; D018528:ATP-Binding Cassette Transporters; D015221:Potassium Channels; D024661:Potassium Channels, Inwardly Rectifying; D011955:Receptors, Drug; D064233:Sulfonylurea Receptors